Measure Development and Endorsement Agenda 

Project Status: Completed

Measure Development and Endorsement Agenda

Access the Final Report: Measure Prioritization Advisory Committee Report

The Opportunity

Despite many ongoing government and private sector efforts to standardize quality measures, quality of health and health care continues to be highly variable in the United States. There is a strong need for the development of quality and cost measures that will ensure broad transparency on the value of care and support performance-based payment and quality improvement around the most prevalent conditions and health risks that account for the greatest share of health care spending. Thus, an assessment and strategic evolution of the current portfolio of measures is needed to ensure that the “right” measures are included.

Section 183 of the Medicare Improvements for Patients and Providers Act of 2008 provides funding for a consensus-based entity to prioritize, endorse, and maintain valid quality performance measures. This legislation and the National Quality Forum’s (NQF’s) subsequent contract with the U.S. Department of Health and Human Services (HHS) afforded NQF with the opportunity for the Formulation of a National Strategy and Priorities for Healthcare Performance Measurement. To achieve these goals, NQF approached the evolution of its endorsed measures portfolio strategically by constructing a working Measure Development and Endorsement Agenda.

About the Project

This project began in March 2010.

Project Factsheet (PDF)  |  Final Report (PDF)

The Measure Prioritization Advisory Committee was charged with identifying priority conditions and measure gap domains and sub-domains for a working Measure Development and Endorsement Agenda. This effort is intended to enhance NQF’s portfolio of endorsed measures and serve as an input to the development of HHS’ National Quality Strategy. These gap areas represent priorities of focus for the field. The domains and sub-domains on each of the gap prioritization lists are considered critical areas for measure development. The voting results reflect the Committee’s relative prioritization of these categories for future measure development.


Key objectives of the project include:

  • Alignment with the development of HHS’ National Quality Strategy;
  • Construction of a clear Agenda to encourage direction of resources to high leverage areas;
  • Continuous scan of the environment to identify and make mid-course corrections, as necessary; and
  • Alignment of this work with expanded public reporting and payment reform in the context of the Affordable Care Act (ACA) and meaningful use in the context of the American Recovery and Reinvestment Act (ARRA), as both of these laws require a robust set of performance measures to serve a variety of needs: meaningful use measures, various new and emerging payment systems, and expanded public reporting.


This project did not follow NQF's formal Consensus Development Process; no products were endorsed. NQF convened the Measure Prioritization Advisory Committee (advisory committee), which was created under previous HHS Task 6 work, to tap its ongoing expertise and build on the 20 Medicare condition and gap prioritization work that they recently completed. The advisory committee was charged with prioritizing measure gaps identified by additional sources or streams of work that define gaps in measures. The project allowed for relevant industry and public input. Further, the review and resulting recommendations were developed in alignment with NQF's role as a national voluntary consensus standards-setting organization.


This project was funded under NQF's contract with the Department of Health and Human Services, Consensus-based Entities Regarding Healthcare Performance Measurement.

Related Work 

Prioritization of High-Impact Conditions 

Contact Information 

For more information, contact Strategic Partnerships at 1-202-783-1300.

Project Search